SAFE-PCI for Women: Radial versus femoral access for women

Radial access is associated with a lower rate of vascular and bleeding complications however female patients with smaller diameter arteries such access might be technically more difficult.

This prospective, randomized, multicenter study compared both approaches in the context of coronary angioplasty in female patients. 1787 patients were randomized (893 in the radial group and 894 in the femoral group). No differences in baseline characteristics were observed in both populations with approximately 40% of diabetics. The study showed no differences in bleeding complications (1.2% radial versus 2.9 % femoral, p = 0.12 ), duration of procedure or cardiovascular complications at 30 days. There was a greater crossover in the group randomized to radial access. Despite this study, exposed no positive results in favor of radial access neither adds an increased risk and showed a trend towards fewer vascular complications as a Dr Roxana Mehran comment.


Sunil V. Rao
2013-10-29

Original title: A Prospective, Registry-Based Randomized Trial of Radial Versus Femoral Vascular Access in Women Undergoing Diagnostic Cardiac Catheterization and PCI.

More articles by this author

SORT OUT VI: Biolimus eluting stent versus zotarolimus-eluting stent; similar results

Few studies have compared head to head the 2nd generation drug eluting stents. This study randomized 1:1  3671 patients to receive a biolimus eluting...

COREVALVE EXTREME RISK: Promising results with CoreValve in very high-risk patients

Percutaneous aortic valve implantation ( TAVI ) recently demonstrated its superiority over medical treatment in patients with severe aortic stenosis and high surgical risk....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...